On August 2, 2021 CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational conditionally activated antibody therapeutics based on its Probody technology platform, reported that Sean McCarthy, D.Phil., president, chief executive officer, and chairman, will participate in the following virtual investor conferences in August (Press release, CytomX Therapeutics, AUG 2, 2021, View Source [SID1234585531]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

BTIG 5th Virtual Biotechnology Conference
Date: Monday, August 9, 2021
Presentation Time: 1:00 p.m. ET.

2021 Wedbush PacGrow Healthcare Virtual Conference
Date: Tuesday, August 10, 2021
Panel Discussion: 1:10 p.m. ET

In addition, management will be available for one-on-one meetings with investors who are registered to attend the conferences.